Activators of viral gene expression in polarized epithelial monolayers identified by rapid-throughput drug screening

Gene Therapy

Volumn 13, Issue 9, 2006, Pages 781-788

  Sorscher, E J ^a,b   Harris, J ^b   Alexander, M ^b   Rottgers, A ^b   Hardy, K ^b   Ponnazhagan, S ^c   Collawn, J F ^d   McClintock, J ^e   Amsler, C D ^e   Webster, A ^f   Maddry, J ^g   Baker, B J ^h   Hong, J S ^b,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f SAMFORD UNIVERSITY   (United States)

^g SOUTHERN RESEARCH INSTITUTE   (United States)

^h UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

AAV; Adenovirus; Compound libraries; High throughput screening; Lentivirus

Indexed keywords

ADENOVIRUS VECTOR; ANTHRANILIC ACID DERIVATIVE; BOUVARDIN; DAUNOMYCIN 3 OXIME; DAUNORUBICIN DERIVATIVE; LENTIVIRUS VECTOR; LIPOSOME; LUCIFERASE; NATURAL PRODUCT; NSC 101492; NSC 109325; NSC 143491; NSC 373989; NSC 675865; NSC 82090; PARVOVIRUS VECTOR; PLANT EXTRACT; PYRIMIDO[4,5 B]QUINOLINE 2,4 (3H,10H)DIONE; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL POLARITY; CELL STRAIN HT29; COLON CARCINOMA; CONTROLLED STUDY; CYSTIC FIBROSIS; DEFENSE MECHANISM; DRUG STRUCTURE; ENZYME ASSAY; EPITHELIUM CELL; GENE EXPRESSION; GENE TRANSFER; GENETIC CODE; GENETIC DISORDER; HELA CELL; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; LUMINESCENCE; PRIORITY JOURNAL; TIGHT JUNCTION; UTERINE CERVIX CARCINOMA; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS INFECTION;

ADENOVIRIDAE; CELL LINE; COMBINED MODALITY THERAPY; DEPENDOVIRUS; DRUG EVALUATION, PRECLINICAL; EPITHELIAL CELLS; GENE EXPRESSION; GENE THERAPY; GENES, VIRAL; GENETIC ENGINEERING; GENETIC VECTORS; HELA CELLS; HUMANS; LENTIVIRUS; LUCIFERASES; PLASMIDS; VIRUSES;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; LENTIVIRUS; PARVOVIRUS;

EID: 33646010347     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302676     Document Type: Article

References (51)

1. Kaludov N, Brown KE, Walters RW, Zabner J, Chiorini JA. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virology 2001; 75: 6884-6893.
2. Kanerva A, Hemminki A. Modified adenoviruses for cancer gene therapy. Int J Cancer 2004; 110: 475-480.
3. Lee JH, Baker TJ, Mahal LK, Zabner J, Bertozzi CR, Wiemer DF et al. Engineering novel cell surface receptors for virus-mediated gene transfer. J Biol Chem 1999; 274: 21878-21884.
4. Nettelbeck DM, Curiel DT. Tumor-busting viruses. Sci Am 2003; 289: 68-75.
5. Walters RW, Grunst T, Bergelson JM, Finberg RW, Welsh MJ, Zabner J. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J Biol Chem 1999; 274: 10219-10226.
6. Zabner J, Freimuth P, Puga A, Fabrega A, Welsh MJ. Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. J Clin Invest 1997; 100: 1144-1149.
7. Ding W, Yan Z, Zak R, Saavedra M, Rodman DM, Engelhardt JF. Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia. J Virol 2003; 77: 7361-7366.
8. Duan D, Yue Y, Yan Z, Yang J, Engelhardt JF. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J Clin Invest 2000; 105: 1573-1587.
9. Chen WY, Bailey EC, McCune SL, Dong JY, Townes TM. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. Proc Natl Acad Sci USA 1997; 94: 5798-5803.
10. Chen WY, Townes TM. Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation. Proc Natl Acad Sci USA 2000; 97: 377-382.
11. Beck C, Cayeux S, Lupton SD, Dorken B, Blankenstein T. The thymidine kinase/ganciclovir-mediated suicide effect is variable in different tumor cell. Hum Gene Ther 1995; 6: 1525-1530.
12. Curlee KV, Parker WB, Sorscher EJ. Tumor sensitization to purine analogs by E. coli PNP. In: Methods in Molecular Medicine, vol. 90. Suicide Gene Therapy: Methods and Reviews. Humana Press, Inc.: Totowa, NJ,, 2004, pp 223-245.
13. Kawamura K, Bahar R, Namba H, Seimiya M, Takenaga K, Hamada H et al. Bystander effect in uracil phosphoribosyltransferase/ 5-fluorouracil-mediated suicide gene therapy is correlated with the level of intercellular communication. Int J Oncol 2001; 18: 117-120.
14. Parker WB, King SA, Allan PW, Bennett Jr LL, Secrist III JA, Montgomery JA et al. In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase. Hum Gene Ther 1997; 8: 1637-1644.
15. Curlee KV, Sorscher EJ. Gene therapy for cystic fibrosis. In: KL Kirk, DC Dawson (eds). Medical Intelligence Unit, The Cystic Fibrosis Transmembrane Conductance Regulator. Kluwer Academic/Plenum: New York, 2003, pp. 201-211.
16. Johnson LG, Olsen JC, Sarkadi B, Moore KL, Swanstrom R, Boucher RC. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet 1992; 2: 21-25.
17. Davies JC, Geddes DM, Alton EW. Prospects for gene therapy in lung disease. Curr Opin Pharmacol 2001; 1: 272-277.
18. Levasseur DN, Ryan TM, Pawlik KM, Townes TM. Correction of a mouse model of sickle cell disease: Lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells. Blood 2003; 102: 4312-4319.
19. Nienhuis AW, Hanawa H, Sawai N, Sorrentino BP, Persons DA. Development of gene therapy for hemoglobin disorders. Ann NY Acad Sci 2003; 996: 101-111.
20. Tinsley R, Eriksson P. Use of gene therapy in central nervous system repair. Acta Neurol Scand 2004; 109: 1-8.
21. West J, Rodman DM. Gene therapy for pulmonary diseases. Chest 2001; 119: 613-617.
22. Augeron C, Laboisse CL. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 1984; 44: 3961-3969.
23. Grubb BR, Pickles RJ, Ye H, Yankaskas JR, Vick RN, Engelhardt JF et al. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 1994; 371: 802-806.
24. Arcasoy SM, Latoche J, Gondor M, Watkins SC, Henderson RA, Hughey R et al. MUC1 and other sialoglycoconjugates inhibit adenovirus-mediated gene transfer to epithelial cells. Am J Respir Cell Mol Biol 1997; 17: 422-435.
25. Pickles RJ, McCarty D, Matsui H, Hart PJ, Randell SH, Boucher RC. Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J Virol 1998; 72: 6014-6023.
26. Wang G, Zabner J, Deering C, Launspach J, Shao J, Bodner M et al. Increasing epithelial junction permeability enhances gene transfer to airway epithelia in vivo. Am J Respir Cell Mol Biol 2000; 22: 129-138.
27. Chu Q, St George JA, Lukason M, Cheng SH, Scheule RK, Eastman SJ. EGTA enhancement of adenovirus-mediated gene transfer to mouse tracheal epithelium in vivo. Hum Gene Ther 2001; 12: 455-467.
28. Stonebraker JR, Wagner D, Lefensty RW, Burns K, Gendler SJ, Bergelson JM et al. Glycocalyx restricts adenoviral vector access to apical receptors expressed on respiratory epithelium in vitro and in vivo: Role for tethered mucins as barriers to lumenal infection. J Virol 2004; 78: 13755-13768.
29. Hutchin ME, Pickles RJ, Yarbrough WG. Efficiency of adenovirus-mediated gene transfer to oropharyngeal epithelial cells correlates with cellular differentiation and human coxsackie and adenovirus receptor expression. Hum Gene Ther 2000; 11: 2365-2375.
30. Finkbeiner WE, Carrier SD, Teresi CE. Reverse transcription-polymerase chain reaction (RT-PCR) phenotypic analysis of cell cultures of human tracheal epithelium, tracheobronchial glands, and lung carcinomas. Am J Respir Cell Mol Biol 1993; 9: 547-556.
31. Shen BQ, Finkbeiner WE, Wine JJ, Mrsny RJ, Widdicombe JH. Calu-3: A human airway epithelial cell line that shows cAMP-dependent Cl- secretion. Am J Physiol 1994; 266: L493-L501.
32. Varga K, Jurkuvenaite A, Wakefield J, Hong JS, Guimbellot JS, Venglarik CJ et al. Efficient intracellular processing of the endogenous cystic fibrosis transmembrane conductance regulator in epithelial cell lines. J Biol Chem 2004; 279: 22578-22584.
33. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
34. Russell DW, Alexander IE, Miller AD. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc Natl Acad Sci USA 1995; 92: 5719-5723.
35. Schaeffer E, Soros VB, Greene WC. Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4T lymphycytes. J Virology 2004; 78: 1375-1383.
36. Bharara S, Sorscher EJ, Gillespie GY, Lindsey JR, Hong JS, Curlee KV et al. Antibiotic-mediated chemoprotection enhances adaptation of E. coli PNP for herpes simplex virus based glioma therapy. Hum Gene Ther 2005; 16: 339-347.
37. Hong JS, Waud WR, Levasseur DN, Townes TM, Wen H, McPherson SA et al. Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the Escherichia coli purine nucleoside phosphorylase gene. Cancer Res 2004; 64: 6610-6615.
38. Kanazawa T, Mizukami H, Nishino H, Okada T, Hanazono Y, Kume A et al. Topoisomerase inhibitors enhance the cytocidal effect of AAV-HSVtk/ ganciclovir on head and neck cancer cells. Int J Oncol 2004; 25: 729-735.
39. Cheng TJ, Brik A, Wong CH, Kan CC. Model system for high-throughput screening of novel human immunodeficiency virus protease inhibitors in Escherichia coli. Antimicrob Agents Chemother 2004; 48: 2437-2447.
40. Kha H, Zhou W, Chen K, Karan-Tamir B, San Miguel T, Zeni L et al. A telomerase enzymatic assay that does not use polymerase chain reaction, radioactivity, or electrophoresis. Anal Biochem 2004; 331: 230-234.
41. Shiloh Y, Andegeko Y, Tsarfaty I. In search of drug treatment for genetic defects in the DNA damage response: The example of ataxia-telangiectasia. Semin Cancer Biol 2004; 14: 295-305.
42. Verkman AS. Drug discovery in academia. Am J Physiol Cell Physiol 2004; 286: C465-C474.
43. Morris AP, Cunningham SA, Benos DJ, Frizzell RA. Cellular differentiation is required for cAMP but not Ca(2+)-dependent Cl- secretion in colonic epithelial cells expressing high levels of cystic fibrosis transmembrane conductance regulator. J Biol Chem 1992; 267: 5575-5583.
44. Morris AP, Cunningham SA, Tousson A, Benos DJ, Frizzell RA. Polarization-dependent apical membrane CFTR targeting underlies cAMP-stimulated Cl- secretion in epithelial cells. Am J Physiol 1994; 266: C254-C268.
45. Weber E, Berta G, Tousson A, St John P, Green MW, Gopalokrishnan U et al. Expression and polarized targeting of a rab3 isoform in epithelial cells. J Cell Biol 1994; 125: 583-594.
46. Auger R, Robin P, Camier B, Vial G, Rossignol B, Tenu JP et al. Relationship between phosphatidic acid level and regulation of protein transit in colonic epithelial cell line HT29-cl19A. J Biol Chem 1999; 274: 28652-28659.
47. Becker TC, Noel RJ, Coats WS, Gomez-Foix AM, Alam T, Gerard RD et al. Use of recombinant adenovirus for metabolic engineering of mammalian cells. In: M Roth (ed). Methods Cell Biology. Academic Press: New York, 1994, pp 161-189.
48. Tollefson AE, Hermiston TW, Wold WSM. Preparation and titration of CsCl-banded adenovirus stock. In: WSM Wold (ed). Adenovirus Methods and Protocols. Humana Press: Totowa, NJ, 1999, pp 1-9.
49. Bennett EM, Anand R, Allan PW, Hassan AE, Hong JS, Levasseur DN et al. Designer gene therapy using an Escherichia coli purine nucleoside phosphorylase/prodrug system. Chem Biol 2003; 10: 1173-1181.
50. Kappes JC, Wu X, Wakefield JK. Production of trans-lentiviral vector with predictable safety. Methods Mol Med 2003; 76: 449-465.
51. Ponnazhagan S, Mahendra G, Kumar S, Thompson JA, Castillas Jr M. Conjugate-based targeting of recombinant adeno-associated virus-2 using avidin-linked ligands. J Virol 2002; 76: 12900-12907.